At a glance

ClinicalIndex Comparison Record

N/ACompleted· 99 enrolled

Drug / intervention

Lindi skin care productsother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00871429

NCT00871429N/ACompleted

Compare CT.gov

Selected Skin Products for Cancer Patients: A Product Satisfaction Survey

Northwestern University·interventional·Posted Mar 30, 2009·Updated Mar 17, 2015

In Brief

A clinical study evaluating Lindi skin care products for Skin Toxicity. Completed, enrolled 99 participants across 1 site.

Detailed Summary

This study is being done because the investigators would like to evaluate product satisfaction of three test products (product A, product B, product C) that are available at any drug store. This will be done by measuring any changes in the subjects' answers to the Skindex-16 questionnaire at two time points (at screening and baseline visit and at follow-up visit) and by evaluating their responses to the product satisfaction survey that will be given to them by a study coordinator.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsSkin Toxicity

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

200920102011201220132014201520162017201820192020202120222023202420252026

Enrollment StartMar 2009

First PostedMar 2009

Primary CompletionNov 2009

Study CompletionAug 2010

TodayJul 2026

First PostedMar 30, 2009

Enrollment StartMar 1, 2009

Primary CompletionNov 1, 2009

Study CompletionAug 1, 2010

TodayJul 2, 2026

Enrollment to primary: 8 monthsPosted 17.3 years ago

Interventions

Lindi skin care productsother

Subjects will then be instructed to apply all three products daily for 1 month. The products include: Lindi Skin soothing balm (product A), Lindi Skin face serum (product B, and Lindi Skin face wash (product C).